Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1839

1.

Total buried bumper syndrome: A case study in transabdominal removal using a technique of endoscopic submucosal dissection.

Nakamura H, Kikuchi S, Ohnuma H, Hirakawa M, Kato J.

Clin Case Rep. 2019 Sep 3;7(10):2012-2013. doi: 10.1002/ccr3.2409. eCollection 2019 Oct.

PMID:
31624631
2.

Pentagamavunon-1 (PGV-1) inhibits ROS metabolic enzymes and suppresses tumor cell growth by inducing M phase (prometaphase) arrest and cell senescence.

Lestari B, Nakamae I, Yoneda-Kato N, Morimoto T, Kanaya S, Yokoyama T, Shionyu M, Shirai T, Meiyanto E, Kato JY.

Sci Rep. 2019 Oct 16;9(1):14867. doi: 10.1038/s41598-019-51244-3.

3.

Mixed chimerism and secondary graft failure in allogeneic hematopoietic stem cell transplantation for aplastic anemia.

Kako S, Yamazaki H, Ohashi K, Ozawa Y, Ota S, Kanda Y, Maeda T, Kato J, Ishiyama K, Matsuoka KI, Miyamoto T, Iida H, Ikegame K, Fukuda T, Ichinohe T, Atsuta Y, Mori T; Adult Aplastic Anemia Working Group of the Japanese Society for Hematopoietic Cell Transplantation.

Biol Blood Marrow Transplant. 2019 Oct 13. pii: S1083-8791(19)30660-3. doi: 10.1016/j.bbmt.2019.10.004. [Epub ahead of print]

PMID:
31618688
4.

Exceptionally rapid response to pembrolizumab in a SMARCA4-deficient thoracic sarcoma overexpressing PD-L1: A case report.

Takada K, Sugita S, Murase K, Kikuchi T, Oomori G, Ito R, Hayasaka N, Miyanishi K, Iyama S, Ikeda H, Kobune M, Emori M, Kato J, Hasegawa T.

Thorac Cancer. 2019 Oct 16. doi: 10.1111/1759-7714.13215. [Epub ahead of print]

PMID:
31617320
5.

The ARH and Macrodomain Families of α-ADP-ribose-acceptor Hydrolases Catalyze α-NAD+ Hydrolysis.

Stevens LA, Kato J, Kasamatsu A, Oda H, Lee DY, Moss J.

ACS Chem Biol. 2019 Oct 10. doi: 10.1021/acschembio.9b00429. [Epub ahead of print]

PMID:
31599159
6.

Cell Cycle Modulation of CHO-K1 Cells Under Genistein Treatment Correlates with Cells Senescence, Apoptosis and ROS Level but in a Dose-Dependent Manner.

Jenie RI, Amalina ND, Ilmawati GPN, Utomo RY, Ikawati M, Khumaira A, Kato JY, Meiyanto E.

Adv Pharm Bull. 2019 Aug;9(3):453-461. doi: 10.15171/apb.2019.054. Epub 2019 Aug 1.

7.

Anti-proliferative and Anti-metastatic Potential of Curcumin Analogue, Pentagamavunon-1 (PGV-1), Toward Highly Metastatic Breast Cancer Cells in Correlation with ROS Generation.

Meiyanto E, Putri H, Arum Larasati Y, Yudi Utomo R, Istighfari Jenie R, Ikawati M, Lestari B, Yoneda-Kato N, Nakamae I, Kawaichi M, Kato JY.

Adv Pharm Bull. 2019 Aug;9(3):445-452. doi: 10.15171/apb.2019.053. Epub 2019 Aug 1.

8.

Durable response after cessation of anti-programmed death 1 therapy in four melanoma patients.

Handa T, Kato J, Sumikawa Y, Hida T, Horimoto K, Sato S, Sawada M, Fujioka M, Minowa T, Matsui Y, Uhara H.

J Dermatol. 2019 Oct 3. doi: 10.1111/1346-8138.15095. [Epub ahead of print] No abstract available.

PMID:
31583754
9.

A Prospective, Longitudinal Observation of the Incidence, Treatment, and Survival of Late Acute and Chronic Graft-versus-Host Disease by National Institutes of Health Criteria in a Japanese Cohort.

Ohwada C, Sakaida E, Igarashi A, Kobayashi T, Doki N, Mori T, Kato J, Koda Y, Kanamori H, Tanaka M, Tachibana T, Fujisawa S, Nakajima Y, Numata A, Toyosaki M, Aoyama Y, Onizuka M, Hagihara M, Koyama S, Kanda Y, Nakasone H, Shimizu H, Kato S, Watanabe R, Shono K, Sakai R, Saito T, Nakaseko C, Okamoto S.

Biol Blood Marrow Transplant. 2019 Sep 16. pii: S1083-8791(19)30627-5. doi: 10.1016/j.bbmt.2019.09.016. [Epub ahead of print]

PMID:
31536824
10.

Japanese real-world study of sequential nivolumab and ipilimumab treament in melanoma.

Tsutsumida A, Fukushima S, Yokota K, Yoshikawa S, Yamasaki O, Tanemura A, Okuyama R, Uhara H, Muto Y, Miyashita A, Akiyama M, Kaji T, Koga H, Kato J, Katayama T, Itakura E, Yamazaki N, Kiyohara Y.

J Dermatol. 2019 Sep 17. doi: 10.1111/1346-8138.15073. [Epub ahead of print]

PMID:
31531895
11.

Ethanol yield and sugar usability in thermophilic ethanol production from lignocellulose hydrolysate by genetically engineered Moorella thermoacetica.

Rahayu F, Tajima T, Kato J, Kato S, Nakashimada Y.

J Biosci Bioeng. 2019 Sep 7. pii: S1389-1723(19)30097-0. doi: 10.1016/j.jbiosc.2019.08.008. [Epub ahead of print]

PMID:
31506242
12.

Augmented blood pressure variability following continuous infusion of noradrenaline in rats.

Jiang D, Kawagoe Y, Asada Y, Kitamura K, Kato J.

J Hypertens. 2019 Sep 9. doi: 10.1097/HJH.0000000000002239. [Epub ahead of print]

PMID:
31503135
13.

Dermoscopy of Melanoma and Non-melanoma Skin Cancers.

Kato J, Horimoto K, Sato S, Minowa T, Uhara H.

Front Med (Lausanne). 2019 Aug 21;6:180. doi: 10.3389/fmed.2019.00180. eCollection 2019. Review.

14.

Transplantation of a decellularized mitral valve complex in pigs.

Inaba Y, Yagi H, Kuroda K, Kato J, Kawai Y, Kasai M, Kitahara H, Ito T, Osako M, Kitagawa Y, Shimizu H.

Surg Today. 2019 Aug 29. doi: 10.1007/s00595-019-01869-8. [Epub ahead of print]

PMID:
31468150
15.

Aberrant resting-state functional connectivity of the dorsolateral prefrontal cortex to the anterior insula and its association with fear avoidance belief in chronic neck pain patients.

Ihara N, Wakaizumi K, Nishimura D, Kato J, Yamada T, Suzuki T, Hashiguchi S, Terasawa Y, Kosugi S, Morisaki H.

PLoS One. 2019 Aug 12;14(8):e0221023. doi: 10.1371/journal.pone.0221023. eCollection 2019.

16.

Functions and regulation of lipocalin-2 in gut-origin sepsis: a narrative review.

Lu F, Inoue K, Kato J, Minamishima S, Morisaki H.

Crit Care. 2019 Aug 2;23(1):269. doi: 10.1186/s13054-019-2550-2. Review.

17.

Transgenic mice overexpressing miR-137 in the brain show schizophrenia-associated behavioral deficits and transcriptome profiles.

Arakawa Y, Yokoyama K, Tasaki S, Kato J, Nakashima K, Takeyama M, Nakatani A, Suzuki M.

PLoS One. 2019 Jul 30;14(7):e0220389. doi: 10.1371/journal.pone.0220389. eCollection 2019.

18.

Implementation of a Brazilian Cardioprotective Nutritional (BALANCE) Program for improvement on quality of diet and secondary prevention of cardiovascular events: A randomized, multicenter trial.

Weber B, Bersch-Ferreira ÂC, Torreglosa CR, Marcadenti A, Lara ES, da Silva JT, Costa RP, Santos RHN, Berwanger O, Bosquetti R, Pagano R, Mota LGS, de Oliveira JD, Soares RM, Galante AP, da Silva SA, Zampieri FG, Kovacs C, Amparo FC, Moreira P, da Silva RA, Dos Santos KG, Monteiro AS, Paiva CCJ, Magnoni CD, Moreira ASB, Peçanha DO, Missias KCS, de Paula LS, Marotto D, Souza P, Martins PRT, Dos Santos EM, Santos MR, Silva LP, Torres RS, Barbosa SNAA, de Pinho PM, de Araujo SHA, Veríssimo AOL, Guterres AS, Cardoso AFR, Palmeira MM, de Ataíde BRB, Costa LPS, Marinho HA, de Araújo CBP, Carvalho HMS, Maquiné RO, Caiado AC, de Matos CH, Barretta C, Specht CM, Onofrei M, Bertacco RTA, Borges LR, Bertoldi EG, Longo A, Ribas BLP, Dobke F, Pretto ADB, Bachettini NP, Gastaud A, Necchi R, Souza GC, Zuchinali P, Fracasso BM, Bobadra S, Sangali TD, Salamoni J, Garlini LM, Shirmann GS, de Los Santos MLP, Bortonili VMS, Dos Santos CP, Bragança GCM, Ambrózio CL, E Lima SB, Schiavini J, Napparo AS, Boemo JL, Nagano FEZ, Modanese PVG, Cunha NM, Frehner C, da Silva LF, Formentini FS, Ramos MEM, Ramos SS, Lucas MCS, Machado BG, Ruschel KB, Beiersdorf JR, Nunes CE, Rech RL, Damiani M, Berbigier M, Poloni S, Vian I, Russo DS, Rodrigues JA, de Moraes MAP, da Costa LM, Boklis M, El Kik RM, Adorne EF, Teixeira JM, Trescastro EP, Chiesa FL, Telles CT, Pellegrini LA, Reis LF, Cardoso RGM, Closs VE, Feres NH, da Silva NF, Silva NE, Dutra ES, Ito MK, Lima MEP, Carvalho APPF, Taboada MIS, Machado MMA, David MM, Júnior DGS, Dourado C, Fagundes VCFO, Uehara RM, Sasso S, Vieira JSO, de Oliveira BAS, Pereira JL, Rodrigues IG, Pinho CPS, Sousa ACS, Almeida AS, de Jesus MT, da Silva GB, Alves LVS, Nascimento VOG, Vieira SA, Coura AGL, Dantas CF, Leda NMFS, Medeiros AL, Andrade ACL, Pinheiro JMF, de Lima LRM, Sabino LS, de Souza CVS, Vasconcelos SML, Costa FA, Ferreira RC, Cardoso IB, Navarro LNP, Ferreira RB, Júnior AES, Silva MBG, Almeida KMM, Penafort AM, de Queirós APO, Farias GMN, Carlos DMO, Cordeiro CGNC, Vasconcelos VB, de Araújo EMVMC, Sahade V, Ribeiro CSA, Araujo GA, Gonçalves LB, Teixeira CS, Silva LMAJ, da Costa LB, Souza TS, de Jesus SO, Luna AB, da Rocha BRS, Santos MA, Neto JAF, Dias LPP, Cantanhede RCA, Morais JM, Duarte RCL, Barbosa ECB, Barbosa JMA, de Sousa RML, Dos Santos AF, Teixeira AF, Moriguchi EH, Bruscato NM, Kesties J, Vivian L, de Carli W, Shumacher M, Izar MCO, Asoo MT, Kato JT, Martins CM, Machado VA, Bittencourt CRO, de Freitas TT, Sant'Anna VAR, Lopes JD, Fischer SCPM, Pinto SL, Silva KC, Gratão LHA, Holzbach LC, Backes LM, Rodrigues MP, Deucher KLAL, Cantarelli M, Bertoni VM, Rampazzo D, Bressan J, Hermsdorff HHM, Caldas APS, Felício MB, Honório CR, da Silva A, Souza SR, Rodrigues PA, de Meneses TMX, Kumbier MCC, Barreto AL, Cavalcanti AB.

Am Heart J. 2019 Sep;215:187-197. doi: 10.1016/j.ahj.2019.06.010. Epub 2019 Jun 21.

19.

Hospital-pharmacy cooperative training and drug-taking compliance in outpatients with chronic pain: a case-control study.

Uejima K, Hayasaka M, Kato J, Sakata W, Otsuka S, Watanabe F, Yoshida Y, Kamei M.

Integr Pharm Res Pract. 2019 Jul 2;8:63-74. doi: 10.2147/IPRP.S197135. eCollection 2019.

20.

Pneumothorax as an Adverse Event in Patients with Lung Metastasis of Soft Tissue Sarcoma under Eribulin Treatment.

Takada K, Murase K, Nakamura H, Hayasaka N, Arihara Y, Iyama S, Ikeda H, Emori M, Sugita S, Nakamura K, Miyanishi K, Kobune M, Kato J.

Intern Med. 2019 Oct 15;58(20):3009-3012. doi: 10.2169/internalmedicine.2790-19. Epub 2019 Jun 27.

21.

Histological transformation in duodenal-type follicular lymphoma: a case report and review of the literature.

Tanigawa T, Abe R, Kato J, Hosoe N, Ogata H, Kameyama K, Okamoto S, Mori T.

Oncotarget. 2019 May 21;10(36):3424-3429. eCollection 2019 May 21.

22.

Paraneoplastic dermatomyositis appearing after nivolumab therapy for gastric cancer: a case report.

Shibata C, Kato J, Toda N, Imai M, Fukumura Y, Arai J, Kurokawa K, Kondo M, Takagi K, Kojima K, Ohki T, Seki M, Yoshida M, Suzuki A, Tagawa K.

J Med Case Rep. 2019 Jun 2;13(1):168. doi: 10.1186/s13256-019-2105-9.

23.

Effects of feeding management on disease incidence and blood metabolites in dairy herds in Iwate Prefecture, Japan.

Kato J, Odate T, Kim YH, Ichijo T, Sato S.

J Vet Med Sci. 2019 Jul 11;81(7):958-967. doi: 10.1292/jvms.18-0742. Epub 2019 May 28.

24.

Late-onset visceral varicella-zoster virus infection presented as acute liver failure after allogeneic hematopoietic stem cell transplantation.

Kikuchi T, Arai M, Koda Y, Kato J, Shimizu T, Katano H, Fujii-Nishimura Y, Sakamoto M, Ebinuma H, Nakamoto N, Kanai T, Okamoto S, Mori T.

Transpl Infect Dis. 2019 Aug;21(4):e13121. doi: 10.1111/tid.13121. Epub 2019 Jun 14.

PMID:
31127967
25.

Successful Treatment of Hepatocellular Carcinoma with Transcatheter Arterial Chemoembolization followed by Radical Liver Transplantation in a Patient with Severe Liver Damage.

Nakamura H, Kawano Y, Miyanishi K, Ishikawa K, Kubo T, Tanaka S, Takada K, Kobune M, Harada K, Kawamura N, Shimamura T, Kanno-Okada H, Kato J.

Case Rep Oncol. 2019 Apr 3;12(1):289-296. doi: 10.1159/000499703. eCollection 2019 Jan-Apr.

26.

Cutaneous apocrine carcinoma with elevated serum cytokeratin 19 fragment 21-1 (CYFRA 21-1).

Fujioka M, Kato J, Sumikawa Y, Sato S, Sawada M, Uhara H.

J Dermatol. 2019 Oct;46(10):e387-e388. doi: 10.1111/1346-8138.14915. Epub 2019 May 14. No abstract available.

PMID:
31087578
27.

Diagnostic efficacy of smear plus liquid-based cytology for EUS-FNA of solid pancreatic lesions: A propensity-matched study.

Itonaga M, Murata SI, Hatamaru K, Tamura T, Nuta J, Kawaji Y, Maekita T, Iguchi M, Kato J, Kojima F, Yamaue H, Kawai M, Okada KI, Hirono S, Shimokawa T, Tanioka K, Kitano M.

Medicine (Baltimore). 2019 May;98(19):e15575. doi: 10.1097/MD.0000000000015575.

28.

EPO-R+ myelodysplastic cells with ring sideroblasts produce high erythroferrone levels to reduce hepcidin expression in hepatic cells.

Miura S, Kobune M, Horiguchi H, Kikuchi S, Iyama S, Murase K, Goto A, Ikeda H, Takada K, Miyanishi K, Kato J.

Blood Cells Mol Dis. 2019 Sep;78:1-8. doi: 10.1016/j.bcmd.2019.04.014. Epub 2019 Apr 30.

PMID:
31082798
29.

[Treatment of POEMS syndrome with lenalidomide and dexamethasone].

Goto A, Iyama S, Sugama Y, Yoshida M, Ibata S, Tatekoshi A, Fujita C, Kikuchi S, Ikeda H, Murase K, Takada K, Kato J, Kobune M.

Rinsho Ketsueki. 2019;60(4):308-313. doi: 10.11406/rinketsu.60.308. Japanese.

PMID:
31068561
30.

Human Herpesvirus 6 Reactivation Evaluated by Digital Polymerase Chain Reaction and Its Association With Dynamics of CD134-Positive T Cells After Allogeneic Hematopoietic Stem Cell Transplantation.

Nakayama H, Yamazaki R, Kato J, Koda Y, Sakurai M, Abe R, Watanuki S, Sumiya C, Shiroshita K, Fujita S, Yamaguchi K, Okamoto S, Mori T.

J Infect Dis. 2019 Aug 9;220(6):1001-1007. doi: 10.1093/infdis/jiz237.

PMID:
31063196
31.

Central pancreatectomy in portal annular pancreas for metastatic renal cell carcinoma: a case report.

Yamaguchi H, Kimura Y, Nagayama M, Imamura M, Tanaka S, Yoshida M, Yoshida E, Fujino H, Machiki T, Miyanishi K, Mizuguchi T, Kato J, Takemasa I.

World J Surg Oncol. 2019 Apr 30;17(1):76. doi: 10.1186/s12957-019-1622-8.

32.

Classification of 3097 patients from the Japanese melanoma study database using the American joint committee on cancer eighth edition cancer staging system.

Fujisawa Y, Yoshikawa S, Minagawa A, Takenouchi T, Yokota K, Uchi H, Noma N, Nakamura Y, Asai J, Kato J, Fujiwara S, Fukushima S, Uehara J, Hoashi T, Kaji T, Fujimura T, Namikawa K, Yoshioka M, Murata N, Ogata D, Matsuyama K, Hatta N, Shibayama Y, Fujiyama T, Ishikawa M, Yamada D, Kishi A, Nakamura Y, Shimiauchi T, Fujii K, Fujimoto M, Ihn H, Katoh N.

J Dermatol Sci. 2019 May;94(2):284-289. doi: 10.1016/j.jdermsci.2019.04.003. Epub 2019 Apr 17.

PMID:
31023613
33.

Diagnostic value of pediatric blood culture bottles for acute postoperative endophthalmitis.

Tanaka T, Ferreira BFA, Oliveira LMS, Kato JM, Gioia TSRD, Rossi F, Nakashima Y, Pimentel SLG, Yamamoto JH, Almeida Junior JN.

Clinics (Sao Paulo). 2019;74:e837. doi: 10.6061/clinics/2019/e837. Epub 2019 Apr 8.

34.

Combination of eribulin plus AKT inhibitor evokes synergistic cytotoxicity in soft tissue sarcoma cells.

Hayasaka N, Takada K, Nakamura H, Arihara Y, Kawano Y, Osuga T, Murase K, Kikuchi S, Iyama S, Emori M, Sugita S, Hasegawa T, Takasawa A, Miyanishi K, Kobune M, Kato J.

Sci Rep. 2019 Apr 8;9(1):5759. doi: 10.1038/s41598-019-42300-z.

35.

Clinical and histopathological characteristics and survival analysis of 4594 Japanese patients with melanoma.

Fujisawa Y, Yoshikawa S, Minagawa A, Takenouchi T, Yokota K, Uchi H, Noma N, Nakamura Y, Asai J, Kato J, Fujiwara S, Fukushima S, Uehara J, Hoashi T, Kaji T, Fujimura T, Namikawa K, Yoshioka M, Murao N, Ogata D, Matsuyama K, Hatta N, Shibayama Y, Fujiyama T, Ishikawa M, Yamada D, Kishi A, Nakamura Y, Shimiauchi T, Fujii K, Fujimoto M, Ihn H, Katoh N.

Cancer Med. 2019 May;8(5):2146-2156. doi: 10.1002/cam4.2110. Epub 2019 Apr 1.

36.

Impact of immunoglobulin G2 subclass level on late-onset bacterial infection after allogeneic hematopoietic stem cell transplantation.

Yamazaki R, Kato J, Koda Y, Sakurai M, Tozawa K, Okayama M, Nakayama H, Watanuki S, Kikuchi T, Hasegawa N, Okamoto S, Mori T.

Transpl Infect Dis. 2019 Jun;21(3):e13086. doi: 10.1111/tid.13086. Epub 2019 Apr 16.

PMID:
30929295
37.

Gastrointestinal Stromal Tumor in a Patient with Neurofibromatosis Type 1 That Was Successfully Treated with Regorafenib.

Fujimi A, Nagamachi Y, Yamauchi N, Tamura F, Kimura T, Miyajima N, Inomata H, Nishisato T, Yoshida M, Takada K, Kobayashi K, Kato J.

Intern Med. 2019 Jul 1;58(13):1865-1870. doi: 10.2169/internalmedicine.2321-18. Epub 2019 Mar 28.

38.

Mirogabalin for the management of postherpetic neuralgia: a randomized, double-blind, placebo-controlled phase 3 study in Asian patients.

Kato J, Matsui N, Kakehi Y, Murayama E, Ohwada S, Sugihara M.

Pain. 2019 May;160(5):1175-1185. doi: 10.1097/j.pain.0000000000001501. Erratum in: Pain. 2019 Aug;160(8):1905.

39.

Beneficial effects of green banana biomass consumption in patients with pre-diabetes and type 2 diabetes: a randomised controlled trial.

Costa ES, França CN, Fonseca FAH, Kato JT, Bianco HT, Freitas TT, Fonseca HAR, Figueiredo Neto AM, Izar MC.

Br J Nutr. 2019 Jun;121(12):1365-1375. doi: 10.1017/S0007114519000576. Epub 2019 Mar 19.

PMID:
30887937
40.

Identification of a Formate-Dependent Uric Acid Degradation Pathway in Escherichia coli.

Iwadate Y, Kato JI.

J Bacteriol. 2019 May 8;201(11). pii: e00573-18. doi: 10.1128/JB.00573-18. Print 2019 Jun 1.

PMID:
30885932
41.

Prediction of treatment outcome and relapse in inflammatory bowel disease.

Kato J, Yoshida T, Hiraoka S.

Expert Rev Clin Immunol. 2019 Jun;15(6):667-677. doi: 10.1080/1744666X.2019.1593140. Epub 2019 Mar 20.

PMID:
30873890
42.

miR-7977 inhibits the Hippo-YAP signaling pathway in bone marrow mesenchymal stromal cells.

Yoshida M, Horiguchi H, Kikuchi S, Iyama S, Ikeda H, Goto A, Kawano Y, Murase K, Takada K, Miyanishi K, Kato J, Kobune M.

PLoS One. 2019 Mar 5;14(3):e0213220. doi: 10.1371/journal.pone.0213220. eCollection 2019.

43.

PARP1 inhibition alleviates injury in ARH3-deficient mice and human cells.

Mashimo M, Bu X, Aoyama K, Kato J, Ishiwata-Endo H, Stevens LA, Kasamatsu A, Wolfe LA, Toro C, Adams D, Markello T, Gahl WA, Moss J.

JCI Insight. 2019 Feb 21;4(4). pii: 124519. doi: 10.1172/jci.insight.124519. eCollection 2019 Feb 21.

44.

Docetaxel therapy for classic Kaposi's sarcoma.

Hosokawa Y, Kato J, Hida T, Horimoto K, Sato S, Sawada M, Sasaki H, Matsui Y, Handa T, Uhara H.

Asia Pac J Clin Oncol. 2019 Jun;15(3):181-182. doi: 10.1111/ajco.13139. Epub 2019 Feb 21. No abstract available.

PMID:
30790461
45.

Efficacy of combined radiotherapy and anti-programmed death 1 therapy in acral and mucosal melanoma.

Kato J, Hida T, Someya M, Sato S, Sawada M, Horimoto K, Fujioka M, Minowa T, Matsui Y, Tsuchiya T, Kitagawa M, Nakata K, Sakata KI, Torigoe T, Uhara H.

J Dermatol. 2019 Apr;46(4):328-333. doi: 10.1111/1346-8138.14805. Epub 2019 Feb 13.

PMID:
30758859
46.

[Bacteriocidal effects of introducing copper products on highly touched areas in hematology ward].

Mori T, Kikuchi T, Sakurai M, Kato J, Koda Y, Abe R, Sumiya C, Yamazaki R, Sugita K, Hasegawa N, Okamoto S.

Rinsho Ketsueki. 2019;60(1):3-6. doi: 10.11406/rinketsu.60.3. Japanese.

PMID:
30726821
47.

Long-term outcomes of patients with Crohn's disease who received infliximab or adalimumab as the first-line biologics.

Inokuchi T, Takahashi S, Hiraoka S, Toyokawa T, Takagi S, Takemoto K, Miyaike J, Fujimoto T, Higashi R, Morito Y, Nawa T, Suzuki S, Nishimura M, Inoue M, Kato J, Okada H.

J Gastroenterol Hepatol. 2019 Aug;34(8):1329-1336. doi: 10.1111/jgh.14624. Epub 2019 Feb 27.

PMID:
30724387
48.

Trastuzumab-Based Combination Chemotherapy in Patients with Human Epidermal Growth Factor Receptor-2-Positive Metastatic Carcinoma ex Pleomorphic Adenoma.

Arihara Y, Murase K, Takada K, Hayasaka N, Miura S, Miyanishi K, Kobune M, Kurose M, Akiyama Y, Sugita S, Kato J.

Case Rep Oncol. 2018 Dec 11;11(3):835-841. doi: 10.1159/000495344. eCollection 2018 Sep-Dec.

49.

Renal dysfunction and anemia associated with long-term imatinib treatment in patients with chronic myelogenous leukemia.

Sakurai M, Kikuchi T, Karigane D, Kasahara H, Matsuki E, Hashida R, Yamane Y, Abe R, Koda Y, Toyama T, Kato J, Shimizu T, Yokoyama Y, Suzuki S, Nakamura T, Okamoto S, Mori T.

Int J Hematol. 2019 Mar;109(3):292-298. doi: 10.1007/s12185-019-02596-z. Epub 2019 Jan 24.

PMID:
30680668
50.

Successful Steroid Therapy for Lipoid Pneumonia Developing After Allogeneic Hematopoietic Stem Cell Transplant: A Case Report.

Sakurai M, Kato J, Toyama T, Hashida R, Yamane Y, Abe R, Koda Y, Kohashi S, Kikuchi T, Hayashi Y, Nukaga S, Ueda S, Fukunaga K, Okamoto S, Mori T.

Transplant Proc. 2018 Dec;50(10):4096-4098. doi: 10.1016/j.transproceed.2018.09.004. Epub 2018 Sep 8.

PMID:
30577323

Supplemental Content

Support Center